Marwood Group, a leading, global healthcare advisory firm known for its deep expertise at the intersection of healthcare policy and commercial strategy, announced today the appointment of Nayan Ghosh as Director, Head of Life Sciences & HealthTech.
After first joining Marwood in 2017 to help expand the market access and commercial strategy capabilities of the Life Sciences & HealthTech practice, Ghosh took a hiatus in 2021 to serve as Head of Commercial & Regulatory Strategy at Arcade Therapeutics, targeting some of the first FDA authorizations for non-drug anxiety and depression treatments.
“Over the last decade, Marwood’s focus on Life Sciences & HealthTech has grown significantly, driven by its synergy with Marwood’s deep expertise, data and analytics capabilities related to healthcare services and delivery. Nayan played a large role in leading this growth, and we are excited to have him return,” said Marwood’s Senior Managing Director Lee Alvarez.
Marwood’s Life Sciences & HealthTech practice provides guidance related to market access, evidence, policy, and commercial strategy to investors, service providers, developers, and manufacturers of emerging innovations with the potential to transform the treatment, management, prevention, or diagnosis of disease.
“The mission of Marwood’s Life Sciences & HealthTech practice is to help life-changing healthcare innovations get into the hands of the patients and practitioners who need them,” said Ghosh. “However, healthcare systems are complex, and regulatory, reimbursement, and policy dynamics are slow to catch up to the dizzying pace of new breakthroughs, ranging from AI-based pathology to cell and gene therapy. I look forward to helping navigate these complexities so that those working on these innovations see success at every stage of their products’ lifecycles.”
About Marwood Group
As healthcare’s premier industry advisor, Marwood Group provides diligence and strategic consulting services to corporations and investors across provider, payor, HIT, outsourced services, and life sciences sectors. Marwood provides in-depth perspectives focused on policy, market strategy, reimbursement, compliance, big data analytics, and operations by leveraging its seasoned global team of healthcare professionals, proprietary data capabilities and extensive stakeholder reach. Marwood is headquartered in New York City with offices in Washington DC and London. To learn more, visit www.marwoodgroup.com or follow us on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240508006905/en/
